← FDA Drug Approvals (Drugs@FDA)

ESBRIET

NDA · New Drug Application · Sponsor: LEGACY PHARMA · Approved 2017-01-11

Drug application

FDA Application #

NDA208780

Application type

New Drug Application

Brand name

ESBRIET

Generic name

PIRFENIDONE

Active ingredients

PIRFENIDONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

LEGACY PHARMA

Manufacturer

Genentech, Inc.

First approval

2017-01-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown